Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Allon Therapeutics Inc NPCUF

Allon Therapeutics, Inc. is a Canada-based Company, which develops treatments for neurodegenerative diseases. The Company is engaged in pre-clinical and clinical development of proprietary neuroprotective compounds which may be applied for the potential treatment of Alzheimer's Disease, Parkinson's Disease, senile dementia, glaucoma, traumatic head injury, neuronal damage due to stroke and... see more

GREY:NPCUF - Post Discussion

Allon Therapeutics Inc > NAPEC COULD BE AN INTERESTING TAKEOVER
View:
Post by modulex on Jul 21, 2016 8:05am

NAPEC COULD BE AN INTERESTING TAKEOVER

NAPEC STOCK HAS LONG BEEN IN THE DUMPS, MARKET-WISE.  IT PUTTED A NEW MANAGEMENT IN PLACE AND THE SHARE PRICE IS SLOWLY GETTING BETTER.  GIVEN THAT THERE WERE ATTEMPTS TAKEOVER BIDS MADE APPARENTLY BY USA QANTAS SERVICES A FEW YEARS AGO AT APPROXIMATELY $2.15/SHARE, WHICH INFORMATION WAS NOT DISCLOSED BY THE FORMER CEO ANDRE LARAMEE, NAPEC COULD AGAIN GET THE ATTENTION OF A USA OR OTHER COMPETITOR.  THE STOCK COULD REACH EASILY $5.00. HOLD ON TO YOUR SHARES.  DONT SELL AND YOU WILL BE GLADLY REWARDED SOMEDAY.
Comment by goldens on Jul 21, 2016 11:02pm
Could not agree more. Started buying this one in the .70's and have no intention of selling. Bought more at $1.08 when it took a pause. This is those once in a blue moon opportunities! Solid management now in place with a good business plan. Even if they don't get taken over this one is only going higher. Buy on the pullbacks. Do your own DD.
Comment by mike49 on Jul 24, 2016 4:27pm
If northern pass gets the approval in New Hampshire  (Quebec side approved),then we will see some interesting politics and company dynamics. Have to get the work of course but they are well positioned. No opinion on former ceo except to say the company appears better without him and I doubt that quantas could ever pass the reg hurdles for a buy out unless they did it piecemeal. Cheers
Comment by fibonnaci on Jul 25, 2016 6:40pm
i agree the northern pass would be huge for napec... but as of the latest updates, the beaurocrats have pushed back site decisions until sept 2017 which sucks... regardless, i think that if trump wins he will announce a huge infrastructure spend immediately and that will give alot of impetus to projects like northern pass which will be a big positive for napec... glta
Comment by MoparHellcat on Aug 04, 2016 5:31pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities